advertisement

WGA Rescources

British Journal of Ophthalmology 14

Showing records 1 to 14 | Display all abstracts in British Journal of Ophthalmology

53751 Evidence of lower macular pigment optical density in chronic open angle glaucoma
Igras E; Loughman J; Ratzlaff M; O'Caoimh R; O'Brien C
British Journal of Ophthalmology 2013; 97: 994-998
53600 Are practical recommendations practiced? A national multi-centre cross-sectional study on frequency of visual field testing in glaucoma
Fung SS; Lemer C; Russell RA; Malik R; Crabb DP
British Journal of Ophthalmology 2013; 97: 843-847
53626 Effect of ageing on the retinal vascular responsiveness to flicker light in glaucoma patients and in ocular hypertension
Gugleta K; Türksever C; Polunina A; Orgül S
British Journal of Ophthalmology 2013; 97: 848-851
53858 Spectral domain optical coherence tomography in children operated for primary congenital glaucoma
Srinivasan S; Addepalli UK; Rao HL; Garudadri CS; Mandal AK
British Journal of Ophthalmology 2014; 98: 162-165
53614 Optical coherence tomography in paediatric glaucoma: time domain versus spectral domain
Ghasia FF; Freedman SF; Rajani A; Holgado S; Asrani S; El-Dairi M
British Journal of Ophthalmology 2013; 97: 837-842
53749 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma
Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R
British Journal of Ophthalmology 2013; 97: 857-861
53739 Twenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertension
Konstas AG; Quaranta L; Katsanos A; Riva I; Tsai JC; Giannopoulos T; Voudouragkaki IC; Paschalinou E; Floriani I; Haidich AB
British Journal of Ophthalmology 2013; 97: 1510-1515
53875 Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week, randomised, double-masked trial
Day DG; Walters TR; Schwartz GF; Mundorf TK; Liu C; Schiffman RM; Bejanian M
British Journal of Ophthalmology 2013; 97: 989-993
53748 Longitudinal changes in anterior chamber depth and axial length in Asian subjects after trabeculectomy surgery
Husain R; Li W; Gazzard G; Foster PJ; Chew PT; Oen FT; Phillips R; Khaw PT; Seah SK; Aung T
British Journal of Ophthalmology 2013; 97: 852-856
53590 Mid-term evaluation of the new Glaukos iStent with phacoemulsification in coexistent open-angle glaucoma or ocular hypertension and cataract
Arriola-Villalobos P; Martínez-de-la-Casa JM; Díaz-Valle D; García-Vidal SE; Fernández-Pérez C; García-Sánchez J; García-Feijoó J
British Journal of Ophthalmology 2013; 97: 1250-1255
53874 Optical coherence tomography of the suprachoroid after CyPass Micro-Stent implantation for the treatment of open-angle glaucoma
Saheb H; Ianchulev T; Ahmed II
British Journal of Ophthalmology 2014; 98: 19-23
53526 Deep sclerectomy versus trabeculectomy: a morphological study with anterior segment optical coherence tomography
Konstantopoulos A; Yadegarfar ME; Yadegarfar G; Stinghe A; Macleod A; Jacob A; Hossain P
British Journal of Ophthalmology 2013; 97: 708-714
53898 Secondary subconjunctival implantation of a biodegradable collagen-glycosaminoglycan matrix to treat ocular hypotony following trabeculectomy with mitomycin C
Dietlein TS; Lappas A; Rosentreter A
British Journal of Ophthalmology 2013; 97: 985-988
53557 Direct healthcare costs of glaucoma treatment
Rahman MQ; Beard SM; Discombe R; Sharma R; Montgomery DM
British Journal of Ophthalmology 2013; 97: 720-724

Issue 15-2

Change Issue


advertisement

Oculus